Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -27.98%1.39B | -38.13%763.03M | -25.93%1.93B | -19.68%1.23B | -3.98%2.61B | 24.55%1.54B | -31.41%2.71B | -43.45%1.23B | 3.57%3.96B | 27.19%2.18B |
| Operating income | -27.98%1.39B | -38.13%763.03M | -25.93%1.93B | -19.68%1.23B | -3.98%2.61B | 24.55%1.54B | -31.41%2.71B | -43.45%1.23B | 3.57%3.96B | 27.19%2.18B |
| Cost of sales | 29.68%-933.11M | 41.38%-504.46M | 20.19%-1.33B | 15.57%-860.57M | -3.78%-1.66B | -39.28%-1.02B | 35.48%-1.6B | 45.41%-731.8M | 4.39%-2.48B | -13.35%-1.34B |
| Operating expenses | 29.68%-933.11M | 41.38%-504.46M | 20.19%-1.33B | 15.57%-860.57M | -3.78%-1.66B | -39.28%-1.02B | 35.48%-1.6B | 45.41%-731.8M | 4.39%-2.48B | -13.35%-1.34B |
| Gross profit | -24.24%456.88M | -30.63%258.58M | -36.06%603.06M | -27.79%372.76M | -15.17%943.1M | 3.04%516.2M | -24.55%1.11B | -40.34%500.96M | 20.46%1.47B | 57.99%839.63M |
| Selling expenses | 0.54%-491.64M | -150.99%-372.86M | -61.28%-494.32M | -23.46%-148.55M | -28.79%-306.49M | -4.96%-120.32M | 52.18%-237.98M | 49.11%-114.64M | -45.72%-497.63M | -119.32%-225.26M |
| Administrative expenses | 7.45%-127.62M | -4.34%-85.83M | 11.43%-137.9M | 76.61%-82.26M | 78.69%-155.7M | -12.55%-351.73M | -63.92%-730.7M | -69.96%-312.52M | -10.45%-445.75M | -10.40%-183.88M |
| Research and development expenses | 44.21%-136.27M | 14.76%-93.91M | 34.03%-244.26M | ---110.17M | ---370.26M | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | 51.72%-336.15M | -29.83%-76.73M | -1,976.15%-696.3M | ---59.1M | ---33.54M | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of financial assets | 51.72%-336.15M | -29.83%-76.73M | -1,976.15%-696.3M | ---59.1M | ---33.54M | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 68.89%-315.4M | 38.61%-63.82M | -539.65%-1.01B | -196.05%-103.95M | -15.67%-158.51M | -283.01%-35.11M | -153.28%-137.03M | 51.07%-9.17M | -3.47%-54.1M | -12.33%-18.74M |
| -Impairment of intangible assets | 86.93%-27.64M | ---- | -6,737.65%-211.56M | ---24.25M | ---3.09M | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | 89.34%-58.27M | 31.58%-11.52M | -735.04%-546.76M | ---16.84M | ---65.48M | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 10.21%-229.48M | 16.81%-52.29M | -184.17%-255.57M | -79.01%-62.86M | 34.37%-89.94M | -283.01%-35.11M | -153.28%-137.03M | 51.07%-9.17M | -3.47%-54.1M | -12.33%-18.74M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -44.97%-16.34M | 31.04%-24.29M | 45.42%-11.27M |
| Special items of operating profit | -339.66%-630.65M | -164.75%-187.98M | -299.90%-143.44M | -309.46%-71.01M | 155.41%71.76M | 155.63%33.9M | -162.86%-129.49M | -349.29%-60.94M | -39.19%205.99M | -65.68%24.45M |
| Operating profit | 25.68%-1.58B | -207.77%-622.55M | -21,973.89%-2.13B | -571.25%-202.28M | 92.20%-9.64M | 439.59%42.92M | -118.78%-123.51M | -102.97%-12.64M | -9.83%657.71M | 43.52%424.93M |
| Financing cost | 0.35%-19.78M | 6.74%-10.36M | -1.09%-19.85M | -12.68%-11.11M | 44.34%-19.64M | ---9.86M | ---35.28M | ---- | ---- | ---- |
| Share of profits of associates | -429.03%-13.19M | -518.92%-11.65M | 13.12%4.01M | -70.76%2.78M | 121.25%3.55M | 242.36%9.51M | -575.58%-16.68M | -189.47%-6.68M | 80.39%-2.47M | -141.71%-2.31M |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | 99.81%-8K | -1,700.00%-54K | -27,640.00%-4.13M | 98.03%-3K |
| Earning before tax | 24.69%-1.61B | -206.04%-644.55M | -8,228.66%-2.14B | -594.71%-210.61M | 85.34%-25.73M | 319.76%42.57M | -126.95%-175.47M | -104.58%-19.37M | -9.17%651.11M | 40.19%422.62M |
| Tax | 326.36%136.7M | 100.98%298K | 360.42%32.06M | -461.44%-30.44M | 70.27%-12.31M | 239.55%8.42M | 27.56%-41.41M | 86.39%-6.04M | -114.88%-57.16M | -74.68%-44.37M |
| After-tax profit from continuing operations | 30.02%-1.48B | -167.27%-644.25M | -5,448.80%-2.11B | -572.70%-241.05M | 82.46%-38.04M | 300.70%51M | -136.52%-216.88M | -106.72%-25.41M | -13.95%593.94M | 37.02%378.25M |
| Earning after tax | 30.02%-1.48B | -167.27%-644.25M | -5,448.80%-2.11B | -572.70%-241.05M | 82.46%-38.04M | 300.70%51M | -136.52%-216.88M | -106.72%-25.41M | -13.95%593.94M | 37.02%378.25M |
| Minority profit | 0.38%-5.79M | -18.07%-5.7M | 67.63%-5.81M | 17.12%-4.83M | -51.64%-17.96M | -66.21%-5.83M | 33.56%-11.85M | 77.05%-3.51M | -60.33%-17.83M | -30.78%-15.28M |
| Profit attributable to shareholders | 30.10%-1.47B | -170.32%-638.55M | -10,383.61%-2.11B | -515.70%-236.22M | 90.21%-20.08M | 359.46%56.82M | -133.52%-205.04M | -105.57%-21.9M | -12.77%611.77M | 36.76%393.53M |
| Basic earnings per share | 34.12%-0.4912 | -148.48%-0.2132 | -10,113.70%-0.7456 | -516.50%-0.0858 | 90.16%-0.0073 | 360.76%0.0206 | -132.47%-0.0742 | -105.19%-0.0079 | -23.63%0.2285 | 23.32%0.1523 |
| Diluted earnings per share | 34.12%-0.4912 | -148.48%-0.2132 | -10,113.70%-0.7456 | -516.50%-0.0858 | 90.16%-0.0073 | 360.76%0.0206 | -132.49%-0.0742 | -105.19%-0.0079 | -23.66%0.2284 | 23.32%0.1523 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unaudited opinion | -- |
| Auditor | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.